Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

PHASE3TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Opioid-induced Constipation
Interventions
DRUG

Tegaserod

Trial Locations (6)

Unknown

60 Investigative Sites, East Hanover

2 Investigative Sites, Hong Kong

6 Investigative Sites, Egypt

1 Investigative Site, Singapore

2 Investigative Sites, Dawan

4 Investigative Sites, Venezuela

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00414024 - Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. | Biotech Hunter | Biotech Hunter